- Home
- AXDX vs CCEL Comparison
AXDX vs CCEL Comparison
Compare AXDX & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXDX
- CCEL
- Stock Information
- Founded
- AXDX 1982
- CCEL 1989
- Country
- AXDX United States
- CCEL United States
- Employees
- AXDX N/A
- CCEL N/A
- Industry
- AXDX Biotechnology: Laboratory Analytical Instruments
- CCEL Managed Health Care
- Sector
- AXDX Industrials
- CCEL Health Care
- Exchange
- AXDX Nasdaq
- CCEL Nasdaq
- Market Cap
- AXDX 41.8M
- CCEL 50.0M
- IPO Year
- AXDX 1996
- CCEL 1997
- Fundamental
- Price
- AXDX $1.20
- CCEL $7.81
- Analyst Decision
- AXDX Hold
- CCEL
- Analyst Count
- AXDX 1
- CCEL 0
- Target Price
- AXDX $1.00
- CCEL N/A
- AVG Volume (30 Days)
- AXDX 63.7K
- CCEL 12.9K
- Earning Date
- AXDX 11-07-2024
- CCEL 12-31-2024
- Dividend Yield
- AXDX N/A
- CCEL 3.13%
- EPS Growth
- AXDX N/A
- CCEL N/A
- EPS
- AXDX N/A
- CCEL N/A
- Revenue
- AXDX $11,909,000.00
- CCEL $31,838,476.00
- Revenue This Year
- AXDX $1.50
- CCEL $3.97
- Revenue Next Year
- AXDX $4.17
- CCEL $0.91
- P/E Ratio
- AXDX N/A
- CCEL N/A
- Revenue Growth
- AXDX N/A
- CCEL 1.95
- 52 Week Low
- AXDX $0.73
- CCEL $4.47
- 52 Week High
- AXDX $4.68
- CCEL $9.50
- Technical
- Relative Strength Index (RSI)
- AXDX 28.60
- CCEL 42.90
- Support Level
- AXDX $1.32
- CCEL $7.60
- Resistance Level
- AXDX $1.42
- CCEL $9.10
- Average True Range (ATR)
- AXDX 0.12
- CCEL 0.28
- MACD
- AXDX -0.04
- CCEL -0.16
- Stochastic Oscillator
- AXDX 10.53
- CCEL 14.58
About AXDX Accelerate Diagnostics Inc.
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.